Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
ASNDAscendis Pharma A/S | $7.87bn | n/a | n/a |
PCVXVaxcyte | $7.65bn | n/a | n/a |
CERECerevel Therapeutics Holdings | $7.42bn | n/a | n/a |
LEGNLegend Biotech | $7.29bn | n/a | n/a |
VKTXViking Therapeutics | $6.87bn | n/a | n/a |
BPMCBlueprint Medicines | $6.61bn | n/a | n/a |
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
RVMDRevolution Medicines | $6.32bn | n/a | n/a |
EXELExelixis | $6.32bn | 29.79 | n/a |
SMMTSummit Therapeutics | $6.10bn | n/a | n/a |
HALOHalozyme Therapeutics | $5.64bn | 18.21 | n/a |
CYTKCytokinetics | $5.56bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
IONSIonis Pharmaceuticals | $5.48bn | n/a | n/a |
MDGLMadrigal Pharmaceuticals | $5.03bn | n/a | n/a |
KRYSKrystal Biotech | $4.57bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $4.56bn | n/a | n/a |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
ALPNAlpine Immune Sciences | $4.46bn | n/a | n/a |
IBRXImmunitybio | $4.44bn | n/a | n/a |